Additionally, low expression of ZNF281 inhibits tumor progression in oral, breast, and cervical cancers (Ji et al. 2020; Hou et al. 2021; Starzynska et al. 2021; Zeng, Hou et al. 2022). This evidence concerns the gene ZNF281 and neoplasm.